Preoperative chemotherapy for resectable thoracic esophageal cancer-Reference-Cited by-同舟云学术

Preoperative chemotherapy for resectable thoracic esophageal cancer

Published:2015-05-19 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Kidane Biniam¹,Coughlin Shaun²,Vogt Kelly¹,Malthaner Richard²

Affiliation:

1. Western University; Division of General Surgery; 339 Windermere Road London ON Canada N6A 5A5

2. Western University; Division of Thoracic Surgery; London Health Sciences Centre 800 Commissioners Rd. E., Suite E2-124 London ON Canada N6A 5W9

Publisher

Wiley

Subject

Pharmacology (medical)

Reference62 articles.

1. Prospective randomized trial of preoperative chemotherapy versus surgery alone in operable squamous cell carcinoma of the esophagus. Preliminary report on response to chemotherapy, pre- and postoperative morbidity and mortality;Ancona;Acta Chirurgica Italica,1995

2. Prognostic role of downstaging after neoadjuvant chemotherapy in potentially resectable (T2-3 Nx M0) esophageal squamous cell carcinoma;Ancona;Canadian Journal of Gastroenterology,1998

3. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone;Ancona;Cancer,2001

4. Prospective evaluation of preoperative chemotherapy in resectable squamous cell carcinoma of the thoracic esophagus;Baba;Diseases of the Esophagus,2000

5. Does preoperative chemotherapy cause adverse effects on the perioperative course of patients undergoing esophagectomy for carcinoma?;Baba;Japanese Journal of Thoracic and Cardiovascular Surgery,1999

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathological characteristics and treatment outcomes of oesophageal cancer patients in Uganda;ecancermedicalscience;2023-07-19

2. Neoadjuvant Management of Adenocarcinoma of the Esophagus and Esophagogastric Junction: Review of Randomized Evidence and Definition of Optimum Treatment Algorithm;Oncology;2023

3. Neoadjuvant immune checkpoint inhibitor in combination with chemotherapy or chemoradiotherapy in resectable esophageal cancer: A systematic review and meta-analysis;Frontiers in Immunology;2022-09-13

4. Predictive Value of Endoscopic Observations and Biopsy After Neoadjuvant Chemoradiotherapy in Assessing the Pathologic Complete Response of Patients With Esophageal Squamous Cell Carcinoma;Frontiers in Oncology;2022-05-11

5. Neoadjuvant Systemic Therapy Prior to Radical Prostatectomy for Clinically Localized High-Risk Prostate Cancer;Frontiers in Urology;2022-03-10